Skip to main content
. 2014 Jun 3;111(1):149–156. doi: 10.1038/bjc.2014.286

Figure 5.

Figure 5

Absolute counts of CD276+ CEC in 4 ml of blood from 24 healthy individuals (HD), 15 patients with advanced CRC (CC), 83 with glioblastoma (GB) and 13 with advanced breast cancer (BC). Solid lines indicate the median value for each group. Differences between HD and cancer patients were significant (*P<0.05; **P<0.01; ***P<0.001).